Characteristics and quantities of HIV host cells in human genital tract secretions

Journal of Infectious Diseases

Volumn 210, Issue , 2014, Pages S609-S615

  Politch, Joseph A ^a   Marathe, Jai ^b   Anderson, Deborah J ^a,b  

^a BOSTON MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AIDS.; Cell Associated; HIV; Infected leukocytes; Mucosal; Rectum; Semen; Transmission; Vagina

Indexed keywords

FEMALE; FEMALE GENITAL SYSTEM; GENITAL SYSTEM DISEASE; GYNECOLOGIC DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE; MALE; MALE GENITAL SYSTEM; PATHOPHYSIOLOGY; PHYSIOLOGY; SECRETION (PROCESS); SPERM; VERTICAL TRANSMISSION; VIROLOGY;

FEMALE; GENITAL DISEASES, FEMALE; GENITAL DISEASES, MALE; GENITALIA, FEMALE; GENITALIA, MALE; HIV; HIV INFECTIONS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; LEUKOCYTES; MALE; SEMEN;

EID: 84925222031     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu390     Document Type: Article

References (111)

1. Hladik F, McElrath MJ. Setting the stage: host invasion by HIV. Nat Rev Immunol 2008; 8:447-57.
2. Kalichman SC, Di Berto G, Eaton L. Human immunodeficiency virus viral load in blood plasma and semen: review and implications of empirical findings. Sex Transm Dis 2008; 35:55-60.
3. Anderson DJ, Politch JA, Nadolski AM, Blaskewicz CD, Pudney J, Mayer KH. Targeting Trojan Horse leukocytes for HIV prevention. AIDS 2010; 24:163-87.
4. Politch JA, Anderson DJ. Semen white blood cell assay. In: Lipshultz LI, Howards SS, Niederberger CS, eds. Infertility in the male. 4th ed. Cambridge: Cambridge University Press, 2009:613-7.
5. Ricci G, Perticarari S, Boscolo R, et al. Leukocytospermia and sperm preparation-A flow cytometric study. Reprod Biol Endocrinol 2009; 7:128.
6. Anderson DJ, Pudney J. Mucosal immunology of the human male genital tract and experimental models. In: Mestecky J, Lamm ME, StroberW, Bienenstock J, McGhee JR, Mayer L, eds. Mucosal immunology. 3rd ed. Vol 2. New York: Elsevier Academic Press, 2005:1647-59.
7. Olivier AJ, Liebenberg LJ, Coetzee D, Williamson AL, Passmore JA, Burgers WA. Isolation and characterization of T cells from semen. J Immunol Methods 2012; 375:223-31.
8. Tomlinson MJ, Barratt CL, Cooke ID. Prospective study of leukocytes and leukocyte subpopulations in semen suggests they are not a cause of male infertility. Fertil Steril 1993; 60:1069-75.
9. Wolff H, Anderson DJ. Immunohistologic characterization and quantitation of leukocyte subpopulations in human semen. Fertil Steril 1988; 49:497-504.
10. Duan YG, Zhang Q, Liu Y, et al. Dendritic cells in semen of infertile men: Association with sperm quality and inflammatory status of the epididymis. Fertil Steril 2014; 101:70-77 e3.
11. Doncel GF, Anderson S, Zalenskaya I. Role of semen in modulating the female genital tract microenvironment-implications for HIV transmission. Am J Reprod Immunol 2014; 71:564-74.
12. Fiore JR, La Grasta L, Di Stefano M, Buccoliero G, Pastore G, Angarano G. The use of serum-free medium delays, but does not prevent, the cytotoxic effects of seminal plasma in lymphocyte cultures: implications for studies on HIV infection. New Microbiol 1997; 20:339-44.
13. Okamoto M, Byrn R, Eyre RC, Mullen T, Church P, Kiessling AA. Seminal plasma induces programmed cell death in cultured peripheral blood mononuclear cells. AIDS Res Hum Retroviruses 2002; 18: 797-803.
14. James K, Harvey J, Bradbury AW, Hargreave TB, Cullen RT. The effect of seminal plasma on macrophage function-A possible contributory factor in sexually transmitted disease. AIDS Res 1983; 1:45-57.
15. Lawrence P, Portran D, Terrasse R, et al. Selective transmigration of monocyte-Associated HIV-1 across a human cervical monolayer and its modulation by seminal plasma. AIDS 2012; 26:785-96.
16. Allen RD, Roberts TK. Role of spermine in the cytotoxic effects of seminal plasma. Am J Reprod Immunol Microbiol 1987; 13:4-8.
17. Politch JA, Mayer KH, Anderson DJ. Depletion of CD4+ T cells in semen during HIV infection and their restoration following antiretroviral therapy. J Acquir Immune Defic Syndr 2009; 50:283-9.
18. Seshadri S, Flanagan B, Vince G, Lewis Jones DI. Leucocyte subpopulations in the seminal plasma and their effects on fertilisation rates in an IVF cycle. Andrologia 2012; 44:396-400.
19. Musey L, Ding Y, Cao J, et al. Ontogeny and specificities of mucosal and blood human immunodeficiency virus type 1-specific CD8(+) cytotoxic T lymphocytes. J Virol 2003; 77:291-300.
20. Quayle AJ, Coston WM, Trocha AK, Kalams SA, Mayer KH, Anderson DJ. Detection of HIV-1-specific CTLs in the semen of HIV-infected individuals. J Immunol 1998; 161:4406-10.
21. Sheth PM, Danesh A, Shahabi K, et al. HIV-specific CD8+ lymphocytes in semen are not associated with reduced HIV shedding. J Immunol 2005; 175:4789-96.
22. WHO. WHO laboratory manual for the examination and processing of human semen. 5th ed. Geneva: WHO Press, 2010.
23. Tomlinson MJ, White A, Barratt CL, Bolton AE, Cooke ID. The removal of morphologically abnormal sperm forms by phagocytes: A positive role for seminal leukocytes? Hum Reprod 1992; 7:517-22.
24. Yanushpolsky EH, Politch JA, Hill JA, Anderson DJ. Antibiotic therapy and leukocytospermia: A prospective, randomized, controlled study. Fertil Steril 1995; 63:142-7.
25. Politch JA, Tucker L, Bowman FP, Anderson DJ. Concentrations and significance of cytokines and other immunologic factors in semen of healthy fertile men. Hum Reprod 2007; 22:2928-35.
26. Politch JA, Mayer KH, Welles SL, et al. Highly active antiretroviral therapy does not completely suppress HIV in semen of sexually active HIV-infected men who have sex with men. AIDS 2012; 26:1535-43.
27. Politch JA, Wolff H, Hill JA, Anderson DJ. Comparison of methods to enumerate white blood cells in semen. Fertil Steril 1993; 60:372-5.
28. Wolff H, Anderson DJ. Male genital tract inflammation associated with increased numbers of potential human immunodeficiency virus host cells in semen. Andrologia 1988; 20:404-10.
29. Anderson DJ, Politch JA. White blood cells in semen and their impact on fertility. In: Centola GM, Ginsburg KA, eds. Evaluation and treatment of the infertile male. Cambridge: Cambridge University Press, 1996:263-76.
30. Hosseinzadeh S, Eley A, Pacey AA. Semen quality of men with asymptomatic chlamydial infection. J Androl 2004; 25:104-9.
31. Neofytou E, Sourvinos G, Asmarianaki M, Spandidos DA, Makrigiannakis A. Prevalence of human herpes virus types 1-7 in the semen of men attending an infertility clinic and correlation with semen parameters. Fertil Steril 2009; 91:2487-94.
32. Bezold G, Politch JA, Kiviat NB, Kuypers JM, Wolff H, Anderson DJ. Prevalence of sexually transmissible pathogens in semen from asymptomatic male infertility patients with and without leukocytospermia. Fertil Steril 2007; 87:1087-97.
33. Cottell E, Harrison RF, McCaffrey M, Walsh T, Mallon E, Barry-Kinsella C. Are seminal fluid microorganisms of significance or merely contaminants? Fertil Steril 2000; 74:465-70.
34. Rajasekaran M, Hellstrom WJ, Naz RK, Sikka SC. Oxidative stress and interleukins in seminal plasma during leukocytospermia. Fertil Steril 1995; 64:166-71.
35. Shimoya K, Matsuzaki N, Ida N, et al. Detection of monocyte chemotactic and activating factor (MCAF) and interleukin (IL)-6 in human seminal plasma and effect of leukospermia on these cytokine levels. Am J Reprod Immunol 1995; 34:311-6.
36. Omu AE, Al-Qattan F, Al-Abdul-Hadi FM, Fatinikun MT, Fernandes S. Seminal immune response in infertile men with leukocytospermia: effect on antioxidant activity. Eur J Obstet Gynecol Reprod Biol 1999; 86:195-202.
37. WHO. Sexually transmitted infections (STIs). Geneva: WHO, 2013.
38. Kasturi SS, Osterberg EC, Tannir J, Brannigan RE. The effect of genital tract infection and inflammation on male infertility. In: Lipshultz LI, Howards SS, Niederberger CS, eds. Infertility in the male. Cambridge: Cambridge University Press, 2009:295-330.
39. Lomas DA, Natin D, Stockley RA, Shahmanesh M. Chemotactic activity of urethral secretions in men with urethritis and the effect of treatment. J Infect Dis 1993; 167:233-6.
40. KaspersenMD, Hollsberg P. Seminal shedding of human herpesviruses. Virol J 2013; 10:226.
41. Ho DD, Schooley RT, Rota TR, et al. HTLV-III in the semen and blood of a healthy homosexual man. Science 1984; 226:451-3.
42. Mayer KH, Boswell S, Goldstein R, et al. Persistence of human immunodeficiency virus in semen after adding indinavir to combination antiretroviral therapy. Clin Infect Dis 1999; 28:1252-9.
43. Belec L, Georges AJ, Steenman G, Martin PM. Antibodies to human immunodeficiency virus in the semen of heterosexual men. J Infect Dis 1989; 159:324-7.
44. Anderson DJ. Genitourinary Immune Defense. In: Holmes KK, Sparling PF, Piot P, Wasserheit JN, Corey L, Cohen M, eds. Sexually transmitted diseases. 4th ed. New York: McGraw-Hill, 2007.
45. Krieger JN, Nirapathpongporn A, Chaiyaporn M, et al. Vasectomy and human immunodeficiency virus type 1 in semen. J Urol 1998; 159:820-5; discussion 825-6.
46. Xu C, Politch JA, Tucker L, Mayer KH, Seage GR III, Anderson DJ. Factors associated with increased levels of human immunodeficiency virus type 1 DNA in semen. J Infect Dis 1997; 176:941-7.
47. Tindall B, Evans L, Cunningham P, et al. Identification of HIV-1 in semen following primary HIV-1 infection. AIDS 1992; 6: 949-52.
48. Atkins MC, Carlin EM, Emery VC, Griffiths PD, Boag F. Fluctuations of HIV load in semen of HIV positive patients with newly acquired sexually transmitted diseases. BMJ 1996; 313:341-2.
49. Vernazza PL, Troiani L, Flepp MJ, et al. Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort Study. AIDS 2000; 14:117-21.
50. Zhang H, Dornadula G, Beumont M, et al. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. N Engl J Med 1998; 339:1803-9.
51. Marina S, Marina F, Alcolea R, et al. Human immunodeficiency virus type 1-serodiscordant couples can bear healthy children after undergoing intrauterine insemination. Fertil Steril 1998; 70:35-9.
52. Quayle AJ, Xu C, Tucker L, Anderson DJ. The case against an association between HIV-1 and sperm: molecular evidence. J Reprod Immunol 1998; 41:127-36.
53. Quayle AJ, Xu C, Mayer KH, Anderson DJ. T lymphocytes and macrophages, but not motile spermatozoa, are a significant source of human immunodeficiency virus in semen. J Infect Dis 1997; 176: 960-8.
54. McCoombe SG, Short RV. Potential HIV-1 target cells in the human penis. AIDS 2006; 20:1491-5.
55. Pudney J, Oneta M, Mayer K, Seage G III, Anderson D. Pre-ejaculatory fluid as potential vector for sexual transmission of HIV-1. Lancet 1992; 340:1470.
56. Calzavara L, Burchell AN, Remis RS, et al. Delayed application of condoms is a risk factor for human immunodeficiency virus infection among homosexual and bisexual men. Am J Epidemiol 2003; 157:210-7.
57. Comhaire F, Bosmans E, Ombelet W, Punjabi U, Schoonjans F. Cytokines in semen of normal men and of patients with andrological diseases. Am J Reprod Immunol 1994; 31:99-103.
58. Galvin SR, Cohen MS. The role of sexually transmitted diseases in HIV transmission. Nat Rev Microbiol 2004; 2:33-42.
59. Cohen MS, Hoffman IF, Royce RA, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet 1997; 349:1868-73.
60. Dyer JR, Eron JJ, Hoffman IF, et al. Association of CD4 cell depletion and elevated blood and seminal plasma human immunodeficiency virus type 1 (HIV-1) RNA concentrations with genital ulcer disease in HIV-1-infected men in Malawi. J Infect Dis 1998; 177:224-7.
61. Pudney J, Quayle AJ, Anderson DJ. Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone. Biol Reprod 2005; 73:1253-63.
62. Anderson DJ, Politch JA, Tucker LD, et al. Quantitation of mediators of inflammation and immunity in genital tract secretions and their relevance to HIV type 1 transmission. AIDS Res Hum Retroviruses 1998; 14(suppl 1):S43-9.
63. Bardeguez AD, Skurnick JH, Perez G, Colon JM, Kloser P, Denny TN. Lymphocyte shedding from genital tract of human immunodeficiency virus-infected women: immunophenotypic and clinical correlates. Am J Obstet Gynecol 1997; 176:158-65.
64. McKinnon LR, Nyanga B, Chege D, et al. Characterization of a human cervical CD4+ T cell subset coexpressing multiple markers of HIV susceptibility. J Immunol 2011; 187:6032-42.
65. Quayle AJ, Kourtis AP, Cu-Uvin S, et al. T-lymphocyte profile and total and virus-specific immunoglobulin concentrations in the cervix of HIV-1-infected women. J Acquir Immune Defic Syndr 2007; 44:292-8.
66. Olmsted SS, Khanna KV, Ng EM, et al. Low pH immobilizes and kills human leukocytes and prevents transmission of cell-Associated HIV in a mouse model. BMC Infect Dis 2005; 5:79.
67. Sabbaj S, Hel Z, Richter HE, Mestecky J, Goepfert PA. Menstrual blood as a potential source of endometrial derived CD3+ T cells. PLoS One 2011; 6:e28894.
68. Bere A, Denny L, Naicker P, Burgers WA, Passmore JA. HIV-specific T-cell responses detected in the genital tract of chronically HIVinfected women are largely monofunctional. Immunology 2013; 139: 342-51.
69. Liebenberg LJ, Gamieldien H, Mkhize NN, et al. Stability and transport of cervical cytobrushes for isolation of mononuclear cells from the female genital tract. J Immunol Methods 2011; 367:47-55.
70. Levine WC, Pope V, Bhoomkar A, et al. Increase in endocervical CD4 lymphocytes among women with nonulcerative sexually transmitted diseases. J Infect Dis 1998; 177:167-74.
71. Cook RL, Redondo-Lopez V, Schmitt C, Meriwether C, Sobel JD. Clinical, microbiological, and biochemical factors in recurrent bacterial vaginosis. J Clin Microbiol 1992; 30:870-7.
72. Brotman RM. Vaginal microbiome and sexually transmitted infections: An epidemiologic perspective. J Clin Invest 2011; 121:4610-7.
73. Bouvet JP, GresenguetG, Belec L. Vaginal pHneutralization by semen as a cofactor of HIV transmission. Clin Microbiol Infect 1997; 3:19-23.
74. Fox CA, Meldrum SJ, Watson BW. Continuous measurement by radio-Telemetry of vaginal pH during human coitus. J Reprod Fertil 1973; 33:69-75.
75. Sharkey DJ, Tremellen KP, Jasper MJ, Gemzell-Danielsson K, Robertson SA. Seminal fluid induces leukocyte recruitment and cytokine and chemokine mRNA expression in the human cervix after coitus. J Immunol 2012; 188:2445-54.
76. Clemetson DB, Moss GB, Willerford DM, et al. Detection of HIV DNA in cervical and vaginal secretions. Prevalence and correlates among women in Nairobi, Kenya. JAMA 1993; 269:2860-4.
77. Cowan FF, Pascoe SJ, Barlow KL, et al. Association of genital shedding of herpes simplex virus type 2 and HIV-1 among sex workers in rural Zimbabwe. AIDS 2006; 20:261-7.
78. John GC, Nduati RW, Mbori-Ngacha D, et al. Genital shedding of human immunodeficiency virus type 1 DNA during pregnancy: Association with immunosuppression, abnormal cervical or vaginal discharge, and severe vitamin A deficiency. J Infect Dis 1997; 175:57-62.
79. Kreiss J, Willerford DM, Hensel M, et al. Association between cervical inflammation and cervical shedding of human immunodeficiency virus DNA. J Infect Dis 1994; 170:1597-601.
80. McClelland RS, Wang CC, Overbaugh J, et al. Association between cervical shedding of herpes simplex virus and HIV-1. AIDS 2002; 16:2425-30.
81. McClelland RS, Wang CC, Mandaliya K, et al. Treatment of cervicitis is associated with decreased cervical shedding of HIV-1. AIDS 2001; 15:105-10.
82. Mostad SB, Kreiss JK, Ryncarz AJ, et al. Cervical shedding of herpes simplex virus in human immunodeficiency virus-infected women: effects of hormonal contraception, pregnancy, and vitamin A deficiency. J Infect Dis 2000; 181:58-63.
83. Mostad SB, Overbaugh J, DeVange DM, et al. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet 1997; 350:922-7.
84. Spinillo A, Zara F, Gardella B, Preti E, Mainini R, Maserati R. The effect of vaginal candidiasis on the shedding of human immunodeficiency virus in cervicovaginal secretions. Am J Obstet Gynecol 2005; 192:774-9.
85. Spinillo A, Debiaggi M, Zara F, Maserati R, Polatti F, De Santolo A. Factors associated with nucleic acids related to human immunodeficiency virus type 1 in cervico-vaginal secretions. BJOG 2001; 108:634-41.
86. Wang CC, McClelland RS, Reilly M, et al. The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1. J Infect Dis 2001; 183:1017-22.
87. Manhart LE, Mostad SB, Baeten JM, Astete SG, Mandaliya K, Totten PA. High Mycoplasma genitalium organism burden is associated with shedding of HIV-1 DNA from the cervix. J Infect Dis 2008; 197:733-6.
88. Anderson BL, Wang CC, Delong AK, et al. Genital tract leukocytes and shedding of genital HIV type 1 RNA. Clin Infect Dis 2008; 47: 1216-21.
89. Mitchell C, Balkus JE, McKernan-Mullin J, et al. Associations between genital tract infections, genital tract inflammation, and cervical cytobrush HIV-1 DNA in US versus Kenyan women. J Acquir Immune Defic Syndr 2013; 62:143-8.
90. Baeten JM, Mostad SB, Hughes MP, et al. Selenium deficiency is associated with shedding of HIV-1-infected cells in the female genital tract. J Acquir Immune Defic Syndr 2001; 26:360-4.
91. McClelland RS, Baeten JM, Overbaugh J, et al. Micronutrient supplementation increases genital tract shedding of HIV-1 in women: results of a randomized trial. J Acquir Immune Defic Syndr 2004; 37: 1657-63.
92. Benki S, Mostad SB, Richardson BA, Mandaliya K, Kreiss JK, Overbaugh J. Increased levels of HIV-1-infected cells in endocervical secretions after the luteinizing hormone surge. J Acquir Immune Defic Syndr 2008; 47:529-34.
93. Mostad SB, Jackson S, Overbaugh J, et al. Cervical and vaginal shedding of human immunodeficiency virus type 1-infected cells throughout the menstrual cycle. J Infect Dis 1998; 178:983-91.
94. Vogt MW, Witt DJ, Craven DE, et al. Isolation patterns of the human immunodeficiency virus from cervical secretions during the menstrual cycle of women at risk for the acquired immunodeficiency syndrome. Ann Intern Med 1987; 106:380-2.
95. Comparison of female to male and male to female transmission of HIV in 563 stable couples. European Study Group on Heterosexual Transmission of HIV. BMJ 1992; 304:809-13.
96. Mattson CL, Bailey RC, Agot K, Ndinya-Achola JO, Moses S. A nested case-control study of sexual practices and risk factors for prevalent HIV-1 infection among young men in Kisumu, Kenya. Sex Transm Dis 2007; 34:731-6.
97. Graham SM, Holte SE, Peshu NM, et al. Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding. AIDS 2007; 21:501-7.
98. Nunnari G, Sullivan J, Xu Y, et al. HIV type 1 cervicovaginal reservoirs in the era of HAART. AIDS Res Hum Retroviruses 2005; 21:714-8.
99. Henning TR, Kissinger P, Lacour N, Meyaski-Schluter M, Clark R, Amedee AM. Elevated cervical white blood cell infiltrate is associated with genital HIV detection in a longitudinal cohort of antiretroviral therapy-Adherent women. J Infect Dis 2010; 202:1543-52.
100. Henin Y, Mandelbrot L, Henrion R, Pradinaud R, Coulaud JP, Montagnier L. Virus excretion in the cervicovaginal secretions of pregnant and nonpregnant HIV-infected women. J Acquir Immune Defic Syndr 1993; 6:72-5.
101. Hillier SL. Normal Genital Flora. In: Holmes KK, Sparling PF, Stamm W, et al. eds. Sexually transmitted diseases. 4th ed. New York: McGraw Hill Medical Publications, 2008:298-308.
102. Rousseau CM, Nduati RW, Richardson BA, et al. Association of levels of HIV-1-infected breast milk cells and risk of mother-To-child transmission. J Infect Dis 2004; 190:1880-8.
103. John GC, Nduati RW, Mbori-Ngacha DA, et al. Correlates of mother-To-child human immunodeficiency virus type 1 (HIV-1) transmission: Association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections. J Infect Dis 2001; 183:206-12.
104. Montano M, Russell M, Gilbert P, et al. Comparative prediction of perinatal human immunodeficiency virus type 1 transmission, using multiple virus load markers. J Infect Dis 2003; 188:406-13.
105. Gaillard P, Verhofstede C, Mwanyumba F, et al. Exposure to HIV-1 during delivery and mother-To-child transmission. AIDS 2000; 14:2341-8.
106. Tugizov SM, Herrera R, Veluppillai P, et al. HIV is inactivated after transepithelial migration via adult oral epithelial cells but not fetal epithelial cells. Virology 2011; 409:211-22.
107. Page-Shafer K, Sweet S, Kassaye S, Ssali C. (C2) Saliva, breast milk, and mucosal fluids in HIV transmission. Adv Dent Res 2006; 19:152-7.
108. Tudor-Williams G, Lyall EG. Mother to infant transmission of HIV. Curr Opin Infect Dis 1999; 12:21-6.
109. Tuomala RE, ODriscoll PT, Bremer JW, et al. Cell-Associated genital tract virus and vertical transmission of human immunodeficiency virus type 1 in antiretroviral-experienced women. J Infect Dis 2003; 187:375-84.
110. Panther LA, Tucker L, Xu C, Tuomala RE, Mullins JI, Anderson DJ. Genital tract human immunodeficiency virus type 1 (HIV-1) shedding and inflammation and HIV-1 env diversity in perinatal HIV-1 transmission. J Infect Dis 2000; 181:555-63.
111. Chaillon A, Samleerat T, Zoveda F, et al. Estimating the timing of mother-To-child transmission of the human immunodeficiency virus type 1 using a viral molecular evolution model. PLoS One 2014; 9: e90421.